DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

Oncology Homepage

New PET imaging method may yield benefits over FDG for detecting certain cancers Gallium-68-labeled FAPI tracer yields promising results

Israeli startup Alpha Tau Medical raises $29 million for novel radiotherapy New brachytherapy approach could be useful for treating several cancers

Dr. Carri Glide-Hurst American Association of Physicists in Medicine elects fellow

Cecilia Danckwardt-Lillieström C-RAD appoints new CFO

Fox Chase Cancer Center gets $673K grant to develop early-stage lung cancer test Taking aim at false positive CT lung scans

Radiotherapy may cause gaps in memory recall for children, says study Trouble recalling specifics of events after treatment

New brachytherapy approach deemed safe for clinical trials First alpha radiation-based cancer treatment for solid tumors

Radiotherapy vacancies rise above three percent, says ASRT survey Vacancies highest in Pacific region of U.S.

AI model strikes balance between dose toxicity and tumor reduction Minimizes dose while still shrinking tumor

Guerbet teams with Imalogix to enhance dose management Utilizes Imalogix's AI-based process and workflow solutions

400 MeV ion Rapid Cycling Medical
Synchrotron in development

Is low cost Proton-to-Carbon Heavy Ion radiotherapy coming soon?

by John R. Fischer , Staff Reporter
Best Particle Therapy, a division of TeamBest Companies, has announced plans to introduce a Proton-to-Carbon Heavy Ion system for highly precise, conformal and hypofractionated radiation therapy.

The 400 MeV ion Rapid Cycling Medical Synchrotron (iRCMS) will be equipped with variable energy and heavy ion treatment technologies to offer a more advanced form of radiotherapy, compared to current options available to patients.

Story Continues Below Advertisement

OR Tables, Treatment/GYN/Uro Chairs, Transport Stretchers, Hospital/ICU Bed

iMS combines the superior service of Oakworks Medical and advanced manufacturing technology of FAMED Medical Solutions. The goal of iMS, "Connecting Art and Medical Science" goes way beyond product with exceptional CareLink service. Contact us today!



“Carbon Heavy Ion can only be produced with at least a 400 MeV Synchrotron,” Krishnan Suthanthiran, founder and president of TeamBest Companies and the Best Cure Foundation, told HCB News. “Our technology is the most sophisticated and yet the simplest solution, providing the most precise, conformal and hypofractionated radiation therapy of five fractions, compared to the range of 30 to 40 fractions found in proton, X-ray, and gamma external-beam radiation therapies.”

An advanced form of radiotherapy, carbon ion therapy targets cancer cells while minimizing damage to surrounding tissue. The treatment utilizes a carbon ion beam to destroy malignant cells and attack cancers resistant to X-rays. Beams are accelerated up to 70 percent of the speed of light and treatment time is shorter than other forms of radiotherapy.

BPT’s 400 MeV iRCMS is designed with intrinsically small beams that enable precise delivery of the most conformal radiation therapy. Its small beam sizes enable it to utilize small magnets and light gantries, creating a reduced footprint.

The system also offers hypofractionated therapy and requires less shielding, due to its highly efficient single turn extraction. It is flexible enough to provide heavy ion beam therapies using protons and/or carbon.

Along with BPT are Best Theratronics Ltd. (BTL), Best Cyclotron Systems (BCS) and Best Medical International (BMI), the other enterprises that make up TeamBest Medical Companies.

BCS currently offers New Advanced Technology Cyclotrons that range from 15 to 70 MeV with as high as 1000 micro Amp current for each device. BCS is developing a Multi-Particle 35 MeV Cyclotron that will utilize alpha, deuteron and proton power as forms of therapy.

TeamBest Companies plan to debut these technologies in express and mobile clinics linked to general and super-specialty medical centers as part of a Hub-and-Spoke Model of Healthcare Delivery System, set up in collaboration with the Best Cure Foundation.

“There are no challenges to bring this globally and in North America,” said Suthanthiran. “The cost of each treatment will be comparable to other external beam radiation therapies.”

TeamBest Companies are not the only manufacturer trying to maximize the potential of carbon ion therapy. Hitachi, for instance, recently acquired Mitsubishi’s proton, carbon and hybrid proton-carbon system technologies. RaySearch also just agreed to install a treatment planning system at a carbon ion therapy facility under construction in Japan.

BPT plans to release its 400 MeV iRCMS in two to three years' time.

Oncology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED